期刊文献+

Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas 被引量:1

Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas
暂未订购
导出
摘要 AIM: Gastrointestinal stromal tumors (GISTs) are rare. GISTs differ from other mesenchymal tumors of the gastrointestinal tract (e.g. leiornyomas and schwannomas). The purpose of this study was to investigate the role of Ets-1 in the growth and differentiation of GISTs. METHODS: Twenty-eight GISTs, nine leiomyomas and six schwannomas were examined by immunohistochemical staining method for Ets-1 in this study. Specimens were selected from surgical pathology archival tissues at Nagasaki University Hospital. RESULTS: Ets-1 protein was expressed in the cytoplasm of cells in all of these tumors. Immunohistochemical staining revealed that 27 GISTs (96.4%), six leiomyomas (66.7%), and five schwannomas (83.3%) were positive for Ets-1. Ets-1 expression was statistically different between GISTs and leiomyomas (P〈0.005). However, there was no correlation between Ets-1 expression and clinical risk categories. CONCLUSION: Ets-1 plays an important role in the growth and differentiation of GISTs, leiomyomas and schwannomas. 瞄准:胃肠的基质肿瘤(大意) 是稀罕的。大意不同于胃肠道的另外的间充质的肿瘤(例如平滑肌瘤和 schwannomas ) 。这研究的目的是在大意的生长和区别调查 Ets-1 的角色。方法:28 大意,九个平滑肌瘤和六 schwannomas 被免疫检验为在这研究的 Ets-1 的组织化学的染色方法。标本从外科病理学被选择在长崎大学医院的档案的纸巾。结果:Ets-1 蛋白质这些肿瘤在所有在房间的细胞质被表示。染色的 Immunohistochemical 表明 27 大意(96.4%) ,六个平滑肌瘤(66.7%) ,和五 schwannomas (83.3%) 为 Ets-1 是积极的。Ets-1 表示在大意和平滑肌瘤(P<0.005 ) 之间是统计上不同的。然而,在 Ets-1 表示和临床的风险范畴之间没有关联。结论:Ets-1 在大意,平滑肌瘤和 schwannomas 的生长和区别起一个重要作用。
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第11期1743-1746,共4页 世界胃肠病学杂志(英文版)
关键词 ETS-1 GISTS LEIOMYOMA Schwannoma Immunohistochemistry Risk category 胃肠肿瘤 肿瘤蛋白 平滑肌瘤 神经鞘瘤
  • 相关文献

参考文献33

  • 1[1]Miettinen M,Lasota J.Gastrointestinal stromal tumors-definition,clinical,histological,immunohistochemical,and molecular genetic features and differential diagnosis.Virchows Arch 2001; 438:1-12
  • 2[2]Miettinen M,Sarlomo-Rikala M,Sobin LH,Lasota J.Esophageal stromal tumors:a clinicopathologic,immunohistochernical,and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.Am J Surg Pathol 2000; 24:211-222
  • 3[3]Miettinen M,Sarlomo-Rikala M,Sobin LH,Lasota J.Gastrointestinal stromal tumors and leiomyosarcomas in the colon:a clinicopathologic,immunohistochemical,and molecular genetic study of 44 cases.Am J Surg Pathol 2000; 24:1339-1352
  • 4[4]Ranchod M,Kempson RL.Smooth muscle tumors of the gastrointestinal tract and retroperitoneum:a pathologic analysis of 100 cases.Cancer 1977; 39:255-262
  • 5[5]Shiu MH,Farr GH,Papachristou DN,Hajdu SI.Myosarcomas of the stomach:natural history,prognostic factors and management.Cancer 1982; 49:177-187
  • 6[6]Ueyama T,Guo KJ,Hashimoto H,Daimaru Y,Enjoji M.A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors.Cancer 1992; 69:947-955
  • 7[7]Appelman HD.Mesenchymal tumors of the gut:historical perspectives,new approaches,new results,and does it make any difference? Monogr Pathol 1990; 220-246
  • 8[8]Sircar K,Hewlett BR,Huizinga JD,Chorneyko K,Berezin I,Riddell RH.Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors.Am J Surg Pathol 1999; 23:377-389
  • 9[9]Sanders KM.A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract.Gastroenterology 1996; 111:492-515
  • 10[10]Miettinen M,Virolainen M,Maarit-Sarlomo-Rikala.Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas.Am J Surg Pathol 1995; 19:207-216

同被引文献5

引证文献1

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部